AzTrials
AzTrials

Surgery--ComplicationsDV_model_CSNCT04884841

Development and Validation of Models to Predict Postoperative Complications for Patients With Cardiac Surgery

An observational study of Surgery--Complications, run by China National Center for Cardiovascular Diseases at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients undergoing cardiac surgery is routinely performed in clinical scenarios, highly postoperative morbidities and long-term mortality should be modified. A simple risk prediction model incorporating risk factors can help guide clinical decision making, patient counseling and treatment planning. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Surgery--Complications
What is being tested?
Patients diagnosed with postoperative complications and Patients without postoperative complications
How many people
70,000 participants
Where
1 siteChina
Study dates
1 Jan 2012to 12 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All adult patients who are going to have an cardiovascular operation.

Who may be able to join

  • Age more than 18 years Undergoing Cardiovascular surgery

Who cannot join

  • Missing primary outcomes or variables

Trial locations and contacts

1 site in 1 country.

Yuefu Wang, MD contact

wangyuefu@hotmail.com

Yuchen Gao, MD contact

gaoyuchen_pumc@hotmail.com

China1 site, 1 recruiting
  • Fuwai Hospital, China National Center for Cardiovascular Diseases, CAMS&PUMC

    Beijing, 100037

    Yuefu Wang, MD, +(86) 010-88396509, wangyuefu@hotmail.com

    Chunrong Wang, MD, +(86) 010-88392469, Emancipation258@outlook.com

    Recruiting

Other trials in China

About this study

Patients undergoing cardiac surgery is routinely performed in clinical scenarios, highly postoperative morbidities and long-term mortality should be modified. A simple risk prediction model incorporating risk factors can help guide clinical decision making, patient counseling and treatment planning.

Read the detailed description

Patients undergoing cardiac surgery is routinely performed in clinical scenarios, highly postoperative morbidities and long-term mortality should be modified.A nomogram is a pictorial representation of a scoring model that possesses a simple user interface and shows favorable predictive performance. By integrating a patient's diverse determinant variables, a nomogram can provide a personalized probability for quantitative predictions of the incidence of an outcome of interest.Therefore, we conducted a retrospective study to assess the incidence, risk factors and outcomes associated with major complications patients undergoing cardiac surgery.

Being tested
Patients diagnosed with postoperative complications, Patients without postoperative complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patients diagnosed with postoperative complicationsOther

    Patients diagnosed with postoperative complications (Acute kidney injury, Chronic Kidney disease, Infection, Delirium, MACCE, Myocardial infarction, Postoperative pulmonary complications, major bleeding, ECMO, IABP....)

  • Patients without postoperative complicationsOther

    Patients without postoperative complications

Study groups in NCT04884841
Study groupRoleWhat they receive
Patients with postoperative complicationsPatients with postoperative complications
Receives: Other: Patients diagnosed with postoperative complications
Patients without postoperative complicationsPatients without postoperative complications
Receives: Other: Patients without postoperative complications

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. postoperative complications: acute kidney injury

    Diagnosed acute kidney injury (KDIGO)

    Measured: 30 dyas

  2. postoperative complications: Chronic Kidney disease

    Diagnosed Chronic Kidney disease

    Measured: 30 days, as follow up

  3. postoperative complications: Infection

    Diagnosed infection

    Measured: 30 days

  4. postoperative complications: delirium

    Diagnosed delirium (CAM,CAM-ICU)

    Measured: 30 days

  5. postoperative complications: MACCE

    Diagnosed MACCE

    Measured: 30 days, as follow up

  6. postoperative complications: major bleeding

    Diagnosed major bleeding

    Measured: 30 days

  7. postoperative complications: postoperative pulmonary complications

    Diagnosed postoperative pulmonary complications

    Measured: 30 days

  8. postoperative complications: ECMO

    patients with ECMO

    Measured: 30 days

  9. postoperative complications: IABP

    patients with IABP

    Measured: 30 days

  10. Ventilation time

    Number of hours the patient with mechanical ventilation

    Measured: Through study completion, an average of 7 days

  11. Length of ICU stay

    Number of days the patient stays in the intensive care unit

    Measured: Through study completion, an average of 30 days

Secondary outcomes (4)
  1. Total hospital costs

    Total cost of the stay in the hospitalization (USD)

    Measured: Through study completion, an average of 30 days

  2. ICU costs

    Total cost of the stay in the intensive care unit (USD)

    Measured: Through study completion, an average of 30 days

  3. Length of hospital stay

    Number of days the patient stays in the hospital

    Measured: Through study completion, an average of 30 days

  4. Length of postoperative hospital stay

    Number of days the patient stays in the hospital after surgery

    Measured: Through study completion, an average of 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2021
  2. Study start1 Jan 2012
  3. Primary completion31 Dec 2021 (estimated)
  4. Study completion12 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
70,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04884841
Sponsor's protocol ID
Prediction Model of CS
Acronym
DV_model_CS
Status last verified
May 2021
First submitted
9 May 2021
Last updated
14 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Surgery--Complications, run by China National Center for Cardiovascular Diseases at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yuefu Wang, MD (wangyuefu@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

postoperative complications: acute kidney injury (time frame: 30 dyas). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in